Shareholders that lost money on Outset Medical, Inc.(OM) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Outset Medical, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Tablo products used in dialysis care [1][2]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from August 1, 2022, to August 7, 2024 [2]. - Allegations include that Outset Medical marketed Tablo products for uses not approved by the FDA, which may lead to a need for additional regulatory applications [2]. - There is a substantial risk that the company could cease sales of Tablo products pending FDA approval, and the company lacks the necessary sales team and processes to effectively ramp up sales [2]. - These factors are expected to adversely impact the company's revenue growth and render previous positive statements about the business misleading [2]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of October 28, 2024, to potentially be appointed as lead plaintiffs [3]. - Registration will provide shareholders with updates throughout the lifecycle of the case, and participation incurs no cost or obligation [3]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].